DSE OSCE EXAM Q&A Latest Update
Course:
DSE
Institution:
DSE
DSE OSCE EXAM Q&A Latest Update
After purchase, you get:
✅ Instant PDF Download
✅ Verified answer explanations
✅ Refund if not Satisfied
✅ Prepared for 2025/2026 test cycle
Document Information
| Uploaded on: | May 12, 2025 |
| Last updated: | May 12, 2025 |
| Number of pages: | 53 |
| Written in: | 2025/2026 |
| Type: | Exam (elaborations) |
| Contains: | Questions & Answers |
| Tags: | DSE OSCE EXAM Q&A Latest Update |
Seller Information
AdelineJean
User Reviews (0)
Exam (Elaborations)
$9.00
Bundle Deal! Get all 6 docs for just $12.00
Add to Cart
100% satisfaction guarantee
Refund Upon dissatisfaction
Immediately available after purchase
Available in Both online and PDF
$9.00
| 0 sold
Related Documents
★ | $9.00
OSCE EXAM 2025-2026 Q&A Latest Update
★ | $10.00
Dental OSCE EXAM Q&A Latest Update
★ | $10.00
Available in a Bundle
Content Preview
DSE OSCE – 2025 Q&A Latest 2025/2026 | 100% PASS What are the ADA recommendations for when pre-med is required Answer -- prosthetic cardiac valves, including transcatheter-implanted prostheses and homografts - prosthetic material used for cardiac valve repair, such as annuloplasty rings and chords - a history of infective endocarditis - a cardiac transplanta with valve regurgitation due to a structurally abnormal valve - the following congenital (present from birth) heart disease --unrepaired cyanotic congenital heart disease, including palliative shunts and conduits --any repaired congenital heart defect with residual shunts or valvular regurgitation at the site of or adjacent to the site of a prosthetic patch or a prosthetic device **ADA website** https://www.ada.org/en/member-center/oral-health-topics/antibioticprophylaxis 41-yo woman, pregnant; prev rheumatic fever with heart murmur (no valvular abnormality); allergy to penicillin. Positive history of infective endocarditis. Does she need to pre med?
Gradesity
We are here to help
Questions? Leave a message!
Newsletter
Get notified upon new uploads. Subscribe to our Newsletter.